• Vitrafy Life Sciences announces an equity raising to raise approximately A$[insert] million
• The raising includes a non-underwritten institutional placement and a share purchase plan
• The presentation is strictly private and confidential, not for distribution in the United States

Vitrafy Life Sciences Limited (ACN 622 720 254) is conducting a non-underwritten equity raising to raise approximately A$[insert] million. This includes an institutional placement of new fully paid ordinary shares and a share purchase plan for eligible shareholders. The presentation is prepared for informational purposes and is strictly private and confidential, not for distribution in the United States. The presentation is not a prospectus or offer document and does not constitute a recommendation to invest. Investors are advised to seek independent financial advice before making any investment decisions.

Vitrafy plans to raise approximately A$[insert] million through the equity raising.

Vitrafy aims to utilize the raised funds to support its foundational infrastructure for the global biologics economy.